Skip to content

Telephone intervention for the control of Fatigue in Cancer patients undergoing Radiotherapy

Telephone intervention for the management of Fatigue in Cancer patients submitted to Radiotherapy: a randomized clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-9p22nj
Enrollment
Unknown
Registered
2017-10-17
Start date
2017-05-15
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

radiotherapy, fatigue, Cancer

Interventions

Experimental group: 64 patients undergoing radiotherapy treatment will receive guidance on fatigue control (physical exercises, energy conservation measures and measures to improve sleep quality) for
Device
Other
N02.421.608

Sponsors

Escola de Saúde Pública do Ceará
Lead Sponsor
Centro Regional Integrado de Oncologia
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age equal or superior to 18 years; to have cognitive ability to follow the guidelines and to respond to Piper's fatigue scale through the application of Mental State Minisease (MMSE); score above 60% on the Karnofsky scale; to have a telephone (landline or cellular) to follow the teaching program.

Exclusion criteria

Exclusion criteria: Patients who reported difficulties in receiving telephone calls; and patients taking antidepressants or with chronic pain.

Design outcomes

Primary

MeasureTime frame
A decrease in fatigue level is expected in patients who participated in the telephone intervention over the weeks of radiotherapy treatment, assessed by applying the Piper Fatigue Scale at the beginning, during and after the intervention.

Secondary

MeasureTime frame
Secondary outcomes are not expected

Countries

Brazil

Contacts

Public ContactAndrea Rodrigues

Universidade Federal do Ceará - Departamento de enfermagem

andreabrodrigues@gmail.com+55(85)989063034

Outcome results

None listed

Source: REBEC (via WHO ICTRP)